DEADLINE: 12TH MAY, 2023
NATIONAL MALARIA ELIMINATION PROGRAMME (NMEP)
INVITATION TO MANUFACTURERS OF ANTIMALARIAL MEDICAL PRODUCTS TO SUBMIT AN EXPRESSION OF INTEREST FOR TECHNICAL ASSISTANCE
The National Malaria Elimination Programme (NMEP) has received financing from the World Bank towards the cost of the Immunization Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) project, and intends to apply part of the proceeds to support the national effort to increase access to antimalarial medicines and Insecticide Treated Nets and to position Nigerian pharmaceutical manufacturers to play a key role in the international tenders to support several malaria program interventions in Nigeria and beyond, in line with the Federal Government Local Content Policy. The National Institute for Pharmaceutical Research and Development (NIPRD) and its technical partner, Bloom Public Health now invite pharmaceutical manufacturers in Nigeria to submit an Expression of Interest for technical assistance towards the attainment of WHO PQ for Antimalarial medicines and Insecticide Treated Nets.
Article 1. Procedure for this invitation to submit an Expression of Interest
Interested current or prospective manufacturers of Antimalarial medicines and Insecticide Treated Nets in Nigeria are, therefore, encouraged to submit their Expression of Interest for technical assistance in the manufacture of WHO PQ Antimalarial medicines.
Expression of Interest does not automatically qualify a company for technical assistance but qualifies the company to be considered among the few to be selected for this program. Every Nigerian registered local manufacturer is qualified for the exercise but only those that show readiness and management commitment would be admitted to the program.
Article 2. Medicinal products invited.
The aim of this invitation is to increase the availability of and sources for Anti-malarial medicines and Insecticide Treated Nets. All anti-malarial medicines included in the WHO treatment guideline qualify for this expression of interest.
Article 3. Selection Process
The selection of companies for the program will be conducted in a very transparent way. The following processes will be followed:
- All the companies that expressed interest in the program will be acknowledged
- A detailed questionnaire to assess readiness and management commitment to the program will be accessible through Bloom Public Health website
- The questionnaires will be reviewed in a transparent way and some companies will be shortlisted and notified
- A gap assessment of the shortlisted companies will be conducted and those ready will be invited to the program
Article 4. Technical assistance to prospective manufacturers of the selected pharmaceutical products following submission of an Expression of Interest
The National Institute for Pharmaceutical Research and Development (NIPRD) and its technical partner, Bloom Public Health will provide technical assistance to selected manufacturers on product formulation and will review factors related to product safety, efficacy, and quality, including product manufacture, quality control systems, and requirements for product testing. Technical assistance will be provided for the preparation of product registration dossiers if needed. The support will also include BA/BE studies.
Article 5. Technical assistance to current manufacturers of the selected pharmaceutical products following submission of an Expression of Interest
After NIPRD and Bloom Public Health’s assessment of the manufacturing site, a review of product data and information will be conducted comparing the data and information to internationally accepted standards such as WHO GMP and other requirements. The National Institute for Pharmaceutical Research and Development (NIPRD) and its technical partner, Bloom Public Health will provide the needed technical assistance to address any discovered deficiencies to ensure the products meet internationally accepted quality standards.
Article 6. Deadline and how to submit an Expression of Interest
To submit an expression of interest, the following documentation must be received via mail or email by Friday May 12, 2023:
1. Cover letter expressing a manufacturer’s interest in receiving technical assistance for the manufacture of the selected pharmaceutical product.
2. A list of anti-malarial medicines the manufacturer currently manufactures or intends to manufacture.
3. Completion of the Questionnaire through Bloom Public Health website (see link below)
Submit required documentation by mail to: WHOPQ@bloompublichealth.com
Bloom Public Health
Suite D6, Mazado Plaza, Mongonu Shettima,
Behind Berger yard Utako, Abuja, Nigeria.
Tel: +234 (0) 816 625 4094
Website link for Questionnaire: http://www.bloompublichealth.com/who-
pq/#form
